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j ourna l  homepage :  www.e lsev ier . com/ loca te / rmed  LETTER TO THE EDITOR Response to Dr. Tsakok’s letter to the editor entitled 
“Comment on tiotropium” We appreciate Dr. AD Tsakok’s interest in our manuscript. 
However, we do not agree with his assertion that our 
analysis is ﬂawed. Our analysis makes an assumption of 
normality and homogeneity of variance. The normality 
assumption is based on central limit theorem as Dr. Tsakok 
argues. A quick examination of standard errors and sample 
sizes provided in Table 3 shows that the variances for the 
two groups are very similar and therefore the homogeneity 
of variance assumption is clearly justiﬁed. No speciﬁc test 
of variances is necessary or even appropriate prior to 
conducting the analysis of covariance. Dr. Tsakok claims to 
have different results which show signiﬁcant differences 
between tiotropium and placebo for the SGRQ total score 
and rescue medication at 3-week follow up which happen 
to be more favorable for tiotropium than what we have 
presented. Our p-values for these comparisons were 
0.0601 and 0.0815. We believe the main reason for the 
differences in results is that Dr. Tsakok exploits the 
normality assumption to a greater degree than we do in 
our analysis. We chose a more conservative and robust 0954-6111/$ - see front matter Published by Elsevier Ltd. 
doi:10.1016/j.rmed.2010.04.019 method than that used by Dr. Tsakok to describe the effect 
of tiotropium. 
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